Skip to content

Yarlap II ECS 323P

by Relevium Labs, Inc.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None

No authorization documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source GUDID, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00860000860031 UDI-DI Date7 Oct 2023ListedStatusListed GUDID: in commercial distribution

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade Name
Yarlap II
Generic Name
Physical therapy transcutaneous neuromuscular electrical stimulation system
Model / Reference
ECS 323P
Primary DI / UDI-DI
00860000860031
510(k) Number
FDA Product Code
KPI
GMDN Term
Physical therapy transcutaneous neuromuscular electrical stimulation system
Device Class
Class II
Regulation Number
876.5320
GUDID distribution status
In Commercial Distribution
Size
Width — 132 Millimeter
Height — 68 Millimeter

Related devices

Category: Physical therapy transcutaneous neuromuscular electrical stimulation system

Other devices from Relevium Labs, Inc.

Properties

  • Over-the-Counter
  • Convenience Kit
  • Lot / Batch Number
  • Serial Number
  • Manufacturing Date

Other properties (9)

  • Sterile: No
  • Single Use: No
  • Implantable: No
  • Contains Latex: No
  • Prescription Use: No
  • Combination Product: No
  • HCT/P: No
  • Premarket Exempt: No
  • Expiration Date: No